Biomarin Pharmaceutical reported $1.08B in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 184.98M 2.54M
Agios Pharmaceuticals AGIO:US $ 1.06M 0.78M
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Amgen AMGN:US $ 35705M 305M
Bayer BAYN:GR € 38061M 1413M
Biogen BIIB:US $ 6277.4M 1.7M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bluebird Bio BLUE:US $ 0M 0M
Insmed INSM:US $ 807.11M 447K
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
IONIS PHARMACEUT IONS:US $ 1248.4M 0.47M
Moderna Inc MRNA:US $ 641M 5M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Ptc Therapeutics PTCT:US $ 981.44M 5.79M
Puma Biotechnology PBYI:US $ 97.68M 0.3M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
United Therapeutics UTHR:US $ 800M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M
YTE INCY:US $ 31.16M 0.23M